Orchestra Biomed Holdings (OBIO)Director sold ~$8.2K
Eric S Fain, Director at Orchestra Biomed Holdings, sold ~$8.2K of Orchestra Biomed Holdings shares.
- ~$8.2K
- Approx. value · 2,683 sh @ $3.05
- 51K
- Holds after · shares reported
- Traded
- Jun 26, 2025
- Filed
- Jun 27, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Apr 29, 2025Insider10% owner purchased ~$127K of OBIO shares in the open market
- Apr 30, 2025Insider10% owner purchased ~$149K of OBIO shares in the open market
- Jun 26, 2025 · this disclosureInsiderDirector sold ~$8.2K of OBIO shares in the open market
What came next
- Aug 1, 2025Insider10% owner purchased ~$1.93M of OBIO shares in the open market
- Aug 4, 2025InsiderDirector purchased ~$55K of OBIO shares in the open market
- Aug 21, 2025InsiderDirector purchased ~$15K of OBIO shares in the open market
- Aug 25, 2025Insider · 3 peopleInsiders: 3 purchases (~$28K)
- Sep 19, 2025Insider · Their first buy on recordDirector purchased ~$2.5K of OBIO shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Orchestra Biomed Holdings
For Orchestra Biomed Holdings, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OBIO page.
Other recent filings by Eric S Fain, Director
- SEC Form 4 at Orchestra Biomed Holdings (OBIO)May 18, 2026
- SEC Form 4 at Orchestra Biomed Holdings (OBIO)Aug 25, 2025
The full history of Eric S Fain, Director is on the profile page.
How this filing works
Other disclosures at Orchestra Biomed Holdings
- SEC Form 4Oct 2, 2026
- SEC Form 4Sep 8, 2026
- SEC Form 4Sep 2, 2026
- SEC Form 4Aug 28, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 4Aug 4, 2026
Everything OQRO holds on this company is on its OBIO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data